Nasdaq Bdtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq bdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bdtx Today - Breaking & Trending Today

Deerfield Management Company L.P. Series C Reduces Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)

Deerfield Management Company L.P. Series C lessened its stake in shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 930,447 shares of the company’s stock after selling 869,553 shares during […] ....

Deerfield Management Companylp Series , Exchange Commission , Jpmorgan Chase Co , Bellevue Group , Kennedy Capital Management , Diamond Therapeutics Inc , Black Diamond Therapeutics , Free Report , Diamond Therapeutics , Visit Holdingschannel , Black Diamond Therapeutics Daily , Nasdaq Bdtx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Contrasting Black Diamond Therapeutics (NASDAQ:BDTX) & Beam Therapeutics (NASDAQ:BEAM)

Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Insider & Institutional Ownership 80.6% of Beam […] ....

United States , United Kingdom , Pfizer Inc , Therapeutics Inc , Verve Therapeutics Inc , Sana Biotechnology Inc , Diamond Therapeutics Inc , Institute Of Molecular , Apellis Pharmaceuticals , Beam Therapeutics Inc , Black Diamond Therapeutics , Get Free Report , Beam Therapeutics , Diamond Therapeutics , Given Black Diamond Therapeutic , Beam Therapeutic , Verve Therapeutics , Sana Biotechnology , Orbital Therapeutics , Clinical Ophthalmology Basel , Black Diamond Therapeutics Daily , Nasdaq Bdtx , Stock Comparison , Stock Analysis ,

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 12.8% in October

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 3,350,000 shares, an increase of 12.8% from the October 15th total of 2,970,000 shares. Approximately 9.8% of the shares of the company are short sold. […] ....

Renaissance Technologies , Capital Management , Newtyn Management , Diamond Therapeutics Inc , Jump Financial , Cubist Systematic Strategies , Black Diamond Therapeutics , Get Free Report , Black Diamond , Systematic Strategies , Diamond Therapeutics , Black Diamond Therapeutics Daily , Nasdaq Bdtx ,

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 24.3% in October

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 2,970,000 shares, an increase of 24.3% from the September 30th total of 2,390,000 shares. Approximately 8.7% of the shares of the company are short sold. […] ....

Piper Sandler , Kennedy Capital Management , Diamond Therapeutics Inc , Diamond Therapeutics Company Profile , Boothbay Fund Management , Black Diamond Therapeutics , Get Free Report , Diamond Therapeutics Trading Down , Diamond Therapeutics , Capital Management , Black Diamond Therapeutics Daily , Nasdaq Bdtx ,